These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 24522918)
1. Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells. Iempridee T; Reusch JA; Riching A; Johannsen EC; Dovat S; Kenney SC; Mertz JE J Virol; 2014 May; 88(9):4811-27. PubMed ID: 24522918 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. Kraus RJ; Yu X; Cordes BA; Sathiamoorthi S; Iempridee T; Nawandar DM; Ma S; Romero-Masters JC; McChesney KG; Lin Z; Makielski KR; Lee DL; Lambert PF; Johannsen EC; Kenney SC; Mertz JE PLoS Pathog; 2017 Jun; 13(6):e1006404. PubMed ID: 28617871 [TBL] [Abstract][Full Text] [Related]
3. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters. Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866 [TBL] [Abstract][Full Text] [Related]
4. The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1. Robinson AR; Kwek SS; Kenney SC PLoS Pathog; 2012 Feb; 8(2):e1002516. PubMed ID: 22346751 [TBL] [Abstract][Full Text] [Related]
5. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency. Robinson AR; Kwek SS; Hagemeier SR; Wille CK; Kenney SC J Virol; 2011 Sep; 85(17):8940-53. PubMed ID: 21697476 [TBL] [Abstract][Full Text] [Related]
6. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation. Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE mBio; 2020 Oct; 11(5):. PubMed ID: 33109754 [TBL] [Abstract][Full Text] [Related]
7. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency. Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393 [TBL] [Abstract][Full Text] [Related]
8. The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1. Raver RM; Panfil AR; Hagemeier SR; Kenney SC J Virol; 2013 Jul; 87(14):8053-63. PubMed ID: 23678172 [TBL] [Abstract][Full Text] [Related]
9. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes. Wang C; Li D; Zhang L; Jiang S; Liang J; Narita Y; Hou I; Zhong Q; Zheng Z; Xiao H; Gewurz BE; Teng M; Zhao B J Virol; 2019 Jul; 93(13):. PubMed ID: 31019051 [TBL] [Abstract][Full Text] [Related]
10. Cellular STAT3 functions via PCBP2 to restrain Epstein-Barr Virus lytic activation in B lymphocytes. Koganti S; Clark C; Zhi J; Li X; Chen EI; Chakrabortty S; Hill ER; Bhaduri-McIntosh S J Virol; 2015 May; 89(9):5002-11. PubMed ID: 25717101 [TBL] [Abstract][Full Text] [Related]
12. Nascent Transcriptomics Reveal Cellular Prolytic Factors Upregulated Upstream of the Latent-to-Lytic Switch Protein of Epstein-Barr Virus. Frey TR; Brathwaite J; Li X; Burgula S; Akinyemi IA; Agarwal S; Burton EM; Ljungman M; McIntosh MT; Bhaduri-McIntosh S J Virol; 2020 Mar; 94(7):. PubMed ID: 31941784 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by Inhibiting BAD-Mediated caspase-3-Dependent Apoptosis. Kim H; Choi H; Lee SK J Virol; 2016 Feb; 90(3):1359-68. PubMed ID: 26581978 [TBL] [Abstract][Full Text] [Related]
14. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival. Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528 [TBL] [Abstract][Full Text] [Related]
15. The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites. Kalla M; Göbel C; Hammerschmidt W J Virol; 2012 Jan; 86(1):447-58. PubMed ID: 22031942 [TBL] [Abstract][Full Text] [Related]
16. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies. Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223 [TBL] [Abstract][Full Text] [Related]
17. Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells. Nawandar DM; Ohashi M; Djavadian R; Barlow E; Makielski K; Ali A; Lee D; Lambert PF; Johannsen E; Kenney SC J Virol; 2017 Apr; 91(8):. PubMed ID: 28179525 [TBL] [Abstract][Full Text] [Related]
18. Reactivation of Epstein-Barr Virus from Latency Involves Increased RNA Polymerase Activity at CTCF Binding Sites on the Viral Genome. Dunn LEM; Lu F; Su C; Lieberman PM; Baines JD J Virol; 2023 Feb; 97(2):e0189422. PubMed ID: 36744959 [TBL] [Abstract][Full Text] [Related]
19. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner. Ellis AL; Wang Z; Yu X; Mertz JE J Virol; 2010 Jun; 84(12):6139-52. PubMed ID: 20375168 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene. Iempridee T; Das S; Xu I; Mertz JE J Virol; 2011 Aug; 85(15):7836-48. PubMed ID: 21593157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]